Variant report
Variant | nsv613073 |
---|---|
Chromosome Location | chr9:1501977-1513917 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs10961794 | chr9:1501977-1501978 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs141428748 | chr9:1501980-1501981 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs11788644 | chr9:1502004-1502005 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
4 | rs571662876 | chr9:1502010-1502011 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs74665546 | chr9:1502011-1502012 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs117450243 | chr9:1502016-1502017 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs182636420 | chr9:1502026-1502027 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs543831136 | chr9:1502029-1502030 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs563751044 | chr9:1502042-1502043 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs114093106 | chr9:1502055-1502056 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs564893965 | chr9:1502074-1502075 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs527502604 | chr9:1502086-1502087 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs7025212 | chr9:1502113-1502114 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
14 | rs187597455 | chr9:1502171-1502172 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs1934242 | chr9:1502176-1502177 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs529975526 | chr9:1502178-1502179 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs549465567 | chr9:1502202-1502203 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs1934241 | chr9:1502210-1502211 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
19 | rs538321166 | chr9:1502213-1502214 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs7044479 | chr9:1502219-1502220 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
21 | rs72692325 | chr9:1502225-1502226 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
22 | rs543302799 | chr9:1502232-1502233 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs535217444 | chr9:1502254-1502255 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs555244815 | chr9:1502286-1502287 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs369465231 | chr9:1502297-1502298 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs192805140 | chr9:1502320-1502321 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs557031344 | chr9:1502328-1502329 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs572694028 | chr9:1502341-1502342 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs577180776 | chr9:1502362-1502363 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs545952113 | chr9:1502364-1502365 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs76192207 | chr9:1502370-1502371 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs184110230 | chr9:1502409-1502410 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs528598076 | chr9:1502415-1502416 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs62534838 | chr9:1502446-1502447 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
35 | rs187283124 | chr9:1502464-1502465 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs62534839 | chr9:1502481-1502482 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
37 | rs569521921 | chr9:1502499-1502500 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs532111546 | chr9:1502500-1502501 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs551922111 | chr9:1502511-1502512 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs192045430 | chr9:1502531-1502532 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs145629403 | chr9:1502570-1502571 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs541172146 | chr9:1502576-1502577 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs568677229 | chr9:1502579-1502580 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs138183251 | chr9:1502598-1502599 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs78290999 | chr9:1502611-1502612 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs372755481 | chr9:1502626-1502627 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs114098884 | chr9:1502645-1502646 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs539805331 | chr9:1502648-1502649 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs552990271 | chr9:1502696-1502697 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs184595664 | chr9:1502709-1502710 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Ovarian cancer | 21720365 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Lynch syndrome | 18415027 | CNVD |
Retinoblastoma | 21504564 | CNVD |
Melanoma | 18172304 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Williams-beuren syndrome | 18553513 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Pilocytic astrocytoma | 18622384 | CNVD |
Pilomyxoid astrocytoma | 18622384 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
prenatal diagnosis | 20453657 | CNVD |
Gastric cancer | 16715143 | CNVD |
Esophageal squamous carcinoma | 18405350 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Intracranial aneurysm | 16715129 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Disorders of sex development | 22290220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Sudden cardiac death | 19188705 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Cancer | 21183584 | CNVD |
Non-small cell lung cancer | 21952639 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Intellectual disability | 22102821 | CNVD |
abnormal development | 18461090 | CNVD |
Honadal dysgenesis | 21048976 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Lung cancer | 16740712 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Breast cancer | 16608533 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Breast cancer | 16272173 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Breast cancer | 17133270 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Cervical cancer | 21063398 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Biliary cancer | 19435499 | CNVD |
Gastric cancer | 21586687 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Myopathy | 18421352 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Acute lymphoblastic leukemia | 18957548 | CNVD |
Myeloproliferative neoplasm | 17564968 | CNVD |
Malignant meningioma | 17937814 | CNVD |
Glioma | 21971842 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 17603634 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chordoma | 18071362 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Chordoma | 21602918 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Developmental delay | 19490664 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
microdeletion syndrome | 16199537 | CNVD |
Non-syndromic sensorineural hearing loss | 21987784 | CNVD |
Cancer | 20164919 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Developmental delay | 21147756 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Lung cancer | 18438408 | CNVD |
Autism | 20531469 | CNVD |
XY gonadal dysgenesis | 20685758 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Oral cancer | 21386901 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Breast cancer | 21785460 | CNVD |
Prostate cancer | 18632612 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 21364760 | CNVD |
Breast cancer | 21858162 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Autism | 22495311 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr9:1491000-1504000 | Weak transcription | Adipose Nuclei | Adipose |
2 | chr9:1504000-1504800 | Strong transcription | Adipose Nuclei | Adipose |
3 | chr9:1504800-1513800 | Weak transcription | Adipose Nuclei | Adipose |
4 | chr9:1511000-1511200 | Enhancers | NHEK | skin |
5 | chr9:1512600-1513000 | Enhancers | Fetal Muscle Leg | muscle |
6 | chr9:1512800-1514200 | Enhancers | NHEK | skin |
7 | chr9:1513000-1513400 | Weak transcription | Fetal Muscle Leg | muscle |
8 | chr9:1513000-1513800 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
9 | chr9:1513200-1514000 | Enhancers | Foreskin Keratinocyte Primary Cells skin02 | Skin |
10 | chr9:1513400-1514800 | Enhancers | Fetal Muscle Leg | muscle |
11 | chr9:1513800-1514600 | Enhancers | Adipose Nuclei | Adipose |